483
PharmaGend Global Medical Services Pte. Ltd.PharmaGend Global Medical Services Pte. Ltd. – FDA 483, Feb 1, 2019
Record Details
During an inspection of Strides Pharma Global Pte Limited in Singapore, the FDA observed deficiencies in control procedures for manufacturing processes, specifically concerning a deficient hold time study protocol. Additionally, the firm's written procedures for cleaning and maintenance were found to lack sufficient detail, particularly regarding the justification of swab sampling locations for equipment cleaning validation.
View Company Profile
ID · 5140edc9-8fca-4280-9e31-5e66344fce88
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.